{
    "organizations": [],
    "uuid": "e1b2093801371bcac749de96d6b292dc7758a95c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sinopharm-group-posts-qtrly-net-pr/brief-sinopharm-group-posts-qtrly-net-profit-attributable-rmb842-7-million-idUSFWN1S31RN",
    "ord_in_thread": 0,
    "title": "Sinopharm Group Posts Qtrly Net Profit Attributable RMB842.7 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - SINOPHARM GROUP CO LTD:\n* QTRLY TOTAL OPERATING REVENUE RMB72.69 BILLION VERSUS RMB68.42 BILLION\n* QTRLY NET PROFIT ATTRIBUTABLE RMB842.7 MILLION VERSUS RMB1.25 BILLION Source text for Eikon:\n ",
    "published": "2018-04-27T07:11:00.000+03:00",
    "crawled": "2018-04-27T17:01:31.025+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "sinopharm",
        "group",
        "co",
        "ltd",
        "qtrly",
        "total",
        "operating",
        "revenue",
        "billion",
        "versus",
        "billion",
        "qtrly",
        "net",
        "profit",
        "attributable",
        "million",
        "versus",
        "billion",
        "source",
        "text",
        "eikon"
    ]
}